ORMP
NASDAQ
$4.10
Oramed Pharmaceuticals Inc (ORMP)
Oramed Pharmaceuticals Inc. is dedicated to the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for the administration of polypeptides. The company is headquartered in New York, New York.
Sector:
Healthcare
Industry:
Biotechnology
Target: $6.25 (+52.44%)
Market Cap
$166M
P/B Ratio
0.70
P/E Ratio
1.50
Free Cash Flow Yield
-5.15%
Price Chart
Valuation
Market Cap$166M
P/E1.50
P/S86.55
P/B0.70
Profitability
Gross Profit (TTM)$13K
EBITDA-$14M
EPS$2.70
Financial Health
Free Cash Flow Yield-5.15%
Growth & Risk
FCF 5Y CAGR-2.19%
Beta (5Y)0.69
Sharpe Ratio1.54